跳至主要内容
临床试验/ISRCTN56543987
ISRCTN56543987已完成不适用

Prevention by HMGCoA reductase inhibition of Acute Lung Injury (ALI) associated with one lung ventilation following oesophagectomy by a reduction of pulmonary vascular dysfunction and inflammatio

The Royal Group of Hospitals Trust (UK)0 个研究点目标入组 40 人开始时间: 2007年5月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • Adult patients undergoing oesophagectomy.

排除标准

  • 1. Age < 18 years
  • 2. Pregnancy
  • 3. Creatine Kinase (CK) > 5 times upper limit of normal range
  • 4. Transaminases > 3 times upper limit of normal range
  • 5. Severe renal impairment (calculated creatinine clearance less than 30 mL/minute)
  • 6. Severe liver disease (Child?s Pugh score > 11)
  • 7. Participation in other trials within 30 days
  • 8. Current treatment with statins
  • 9. Inability to take oral medication pre-operatively
  • 10. Patients taking corticosteroids or non-steroidal anti-inflammatory drugs
  • 11. Consent declined

研究者

发起方
The Royal Group of Hospitals Trust (UK)

相似试验

Prevention by HMGCoA reductase inhibition of Acute... | 临床试验